Careers  |  Sign In  |  Register  |   Twitter

Genetic Test Gauges Patients’ Pain Tolerance and Addiction Risk

Opioid addiction in the United States has reached epidemic proportions. Opioid prescriptions have quadrupled since 1999, and deaths attributed to prescription opioid overdoses have also risen four-fold in the same span of time. Proove Biosciences wants to give physicians better tools to more accurately measure their patients’ pain thresholds, levels of pain, and propensity for addictive behavior. It’s all too clear that asking patients to pick a number between 1 and 10 is not the most reliable way to evaluate pain and make prescription decisions.